Company / PP&E per Share
Praxis Precision Medicines, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.32
FY2021-FY2025
Trend
-71.1%
vs FY2024
Sector context
#168 of 191
Health Care
What the data says
Praxis Precision Medicines, Inc.'s pp&e per share of $0.01 is lower than 88% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 3 consecutive years, from $0.32 in FY2022 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -3.7%.
Declined from $0.18 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -71.2%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 191This company $0.01 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- Praxis Precision Medicines, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 71.1% year-over-year.
- Ranks #168 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -71.1% |
| FY2024 | $0.03 | -85.4% |
| FY2023 | $0.18 | -43.5% |
| FY2022 | $0.32 | +1005.9% |
| FY2021 | $0.03 | +211.9% |
| FY2020 | $0.01 | -89.1% |
| FY2019 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026